In view of the need to identify the early signs of kidney involvement, this study was aimed at exploring the role of the urinary biomarkers NGAL, TIMP-2, and IGFBP7 for the early detection of AKI in critically ill patients with COVID-19. This evidence concerns the gene LCN2 and COVID-19.